EverPoint Asset Management’s Boston Scientific BSX Stock Holding History

EverPoint Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$15.5M	Buy	715,000 +465,000	+186%	+$10.1M	0.29%	96
2016 Q3	$5.95M	Buy	+250,000	New	+$5.96M	0.11%	218
2015 Q2	–	Sell	-700,000	Closed	-$12.4M	–	456
2015 Q1	$12.4M	Sell	700,000 -1,015,000	-59%	-$16M	0.24%	138
2014 Q4	$22.7M	Buy	1,715,000 +1,140,000	+198%	+$14.6M	0.51%	53
2014 Q3	$6.79M	Buy	575,000 +175,000	+44%	+$2.2M	0.16%	210
2014 Q2	$5.11M	Buy	+400,000	New	+$5.2M	0.11%	261

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EverPoint Asset Management's BSX Position: Q4 2016 in Review

EverPoint Asset Management increased its Boston Scientific (BSX) stake by 186% in Q4 2016, buying an estimated $10.1M and bringing the position to 715,000 shares worth $15.5M. The position accounts for 0.29% of the portfolio, ranked #96.

EverPoint Asset Management first reported a position in BSX in Q2 2014 and has held it in 6 quarters since. The position peaked at $22.7M in Q4 2014. 557 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

EverPoint Asset Management held 715,000 shares of Boston Scientific worth $15.5M as of Q4 2016.
EverPoint Asset Management bought 465,000 Boston Scientific shares in Q4 2016, an estimated $10.1M.
Boston Scientific made up 0.29% of EverPoint Asset Management's portfolio in Q4 2016, its #96 holding.
EverPoint Asset Management first reported a position in Boston Scientific in Q2 2014 and has held it in 6 quarters since.
EverPoint Asset Management's Boston Scientific position peaked at $22.7M in Q4 2014.
557 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.